Search
Dr Mohammad Naveed Sarwar

Dr Mohammad Naveed Sarwar

Naveed Sarwar

Medical oncology 04324788

  • is not fee assuredNot Fee assured
  • Open Referral network
Overview
Not Fee assured
Open Referral network

Offers

  • Face-to-face consultations
  • Home chemotherapy

About me

Dr Naveed Sarwar was appointed to Imperial College Healthcare NHS trust in 2014 to lead the Medical Oncology group, in the treatment of urological cancers having previously been a Consultant at Barts Health NHS trust since 2008. He is the deputy lead for the Charing Cross Trophoblast Screening and Treatment Centre. He is a member of the National Cancer Research Institute clinical studies group for testicular cancer and also a member of the National Cancer Research Institute clinical studies group for metastatic bladder cancer.
Dr Sarwar is very actively involved in clinical trial research leading a spectrum of clinical studies from phase II to randomized Phase III. He is the lead for urological medical oncology at Charing Cross Hospital, and the research lead for the treatment of urological cancers within NW Thames network. He has co-authored papers on urological cancers and Gestational Trophoblast Disease in peer-reviewed journals. He is a member of both the European and American Societies of Oncology and a keen participant in their annual meetings.

Areas of interest

Urological oncology; Kidney Cancer; Prostate Cancer; Bladder Cancer; Testicular Cancer; Ovarian Germ Cell Cancer; Molar Pregnancy; Gestational Trophoblastic Disease; Immunotherapy

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0003

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)

    Charing Cross Hospital (5-50)

  • X0004

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)

    Charing Cross Hospital (5-50)

Report this page Edit details

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.